Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
暂无分享,去创建一个
[1] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[2] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[3] R. Califf,et al. Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial. , 1995, Journal of the American College of Cardiology.
[4] R. Baltazar,et al. Is thrombolytic therapy safe during active menstruation? , 1995, The Journal of emergency medicine.
[5] R. Jesse,et al. Safety of thrombolytic therapy in normally menstruating women with acute myocardial infarction. , 1994, The American journal of cardiology.
[6] D. W. Lee,et al. Front-Loaded Infusion Therapy of rT-PA During Active Menstruation , 1994, Angiology.
[7] T. Linnemeier,et al. Thrombolytic Therapy for Acute Myocardial Infarction in Actively Menstruating Women , 1993, Annals of Internal Medicine.
[8] C. Conti. Is menstruation a contraindication to thrombolytic therapy? , 1992, Clinical cardiology.
[9] W. M. Chop,et al. Thrombolytic therapy during active menstruation: a case report. , 1991, The Journal of family practice.
[10] J. Haft,et al. Administration of intracoronary streptokinase during menstruation. , 1985, American heart journal.
[11] D. Simel,et al. Is streptokinase safe during menses? , 1984, Archives of internal medicine.
[12] J. Sixma,et al. Hemostasis in menstrual endometrium: a review. , 1982, Obstetrical & gynecological survey.